D. E. Shaw & Co., Inc. Danaher Corp Transaction History

D. E. Shaw & Co., Inc.

$98.6 Billion
Q2 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Danaher Corp stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 2,700 shares of DHR stock, worth $668,952. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,700

Previous 5,699 52.62%

Holding current value

$668,952

Previous $1.42 Million 52.64%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$235.51 - $267.98 $706,294 - $803,672	-2,999 Reduced 52.62%	2,700 $674,000
Q1 2024 May 15, 2024	SELL	$224.58 - $256.19 $4.33 Million - $4.93 Million	-19,263 Reduced 77.17%	5,699 $1.42 Million
Q4 2023 Feb 14, 2024	SELL	$185.1 - $233.13 $29 Million - $36.6 Million	-156,891 Reduced 86.27%	24,962 $5.77 Million
Q3 2023 Nov 14, 2023	SELL	$233.08 - $265.59 $165 Million - $188 Million	-709,721 Reduced 79.6%	181,853 $45.1 Million
Q2 2023 Aug 14, 2023	BUY	$224.99 - $256.14 $70.6 Million - $80.4 Million	313,798 Added 54.31%	891,574 $214 Million
Q1 2023 May 15, 2023	BUY	$239.75 - $277.0 $52 Million - $60 Million	216,776 Added 60.05%	577,776 $146 Million
Q4 2022 Feb 14, 2023	BUY	$241.42 - $282.29 $48 Million - $56.1 Million	198,899 Added 122.7%	361,000 $95.8 Million
Q3 2022 Nov 14, 2022	SELL	$247.06 - $1507.4 $17.1 Million - $104 Million	-69,089 Reduced 29.88%	162,101 $41.9 Million
Q2 2022 Aug 15, 2022	BUY	$237.11 - $299.66 $34.9 Million - $44.1 Million	147,101 Added 174.93%	231,190 $58.6 Million
Q1 2022 May 16, 2022	BUY	$257.27 - $315.76 $4.4 Million - $5.4 Million	17,112 Added 25.55%	84,089 $24.7 Million
Q4 2021 Feb 14, 2022	SELL	$292.08 - $329.01 $38.5 Million - $43.4 Million	-131,880 Reduced 66.32%	66,977 $22 Million
Q3 2021 Nov 15, 2021	BUY	$272.21 - $332.43 $47.3 Million - $57.8 Million	173,723 Added 691.19%	198,857 $60.5 Million
Q2 2021 Aug 16, 2021	SELL	$225.08 - $271.69 $22.9 Million - $27.7 Million	-101,863 Reduced 80.21%	25,134 $6.75 Million
Q1 2021 May 17, 2021	SELL	$212.38 - $245.9 $3.05 Million - $3.53 Million	-14,373 Reduced 10.17%	126,997 $28.6 Million
Q4 2020 Feb 16, 2021	BUY	$212.5 - $245.46 $18.4 Million - $21.2 Million	86,392 Added 157.14%	141,370 $31.4 Million
Q3 2020 Nov 16, 2020	BUY	$177.16 - $215.33 $880,308 - $1.07 Million	4,969 Added 9.94%	54,978 $11.8 Million
Q2 2020 Aug 14, 2020	SELL	$128.7 - $176.83 $29.4 Million - $40.5 Million	-228,804 Reduced 82.06%	50,009 $8.84 Million
Q1 2020 May 15, 2020	BUY	$121.39 - $169.05 $23.2 Million - $32.4 Million	191,520 Added 219.4%	278,813 $38.6 Million
Q4 2019 Feb 14, 2020	SELL	$133.47 - $153.48 $26.4 Million - $30.4 Million	-197,883 Reduced 69.39%	87,293 $13.4 Million
Q3 2019 Nov 14, 2019	BUY	$135.4 - $146.47 $2.71 Million - $2.93 Million	19,996 Added 7.54%	285,176 $41.2 Million
Q2 2019 Aug 14, 2019	BUY	$124.88 - $143.73 $28.3 Million - $32.5 Million	226,305 Added 582.14%	265,180 $37.9 Million
Q1 2019 May 15, 2019	SELL	$97.62 - $132.29 $37 Million - $50.2 Million	-379,156 Reduced 90.7%	38,875 $5.13 Million
Q4 2018 Feb 14, 2019	SELL	$94.85 - $109.54 $170 Million - $197 Million	-1,795,870 Reduced 81.12%	418,031 $43.1 Million
Q3 2018 Nov 14, 2018	BUY	$98.13 - $108.9 $9.81 Million - $10.9 Million	99,925 Added 4.73%	2,213,901 $241 Million
Q2 2018 Aug 14, 2018	BUY	$96.1 - $103.24 $82.8 Million - $89 Million	861,651 Added 68.8%	2,113,976 $209 Million
Q1 2018 May 15, 2018	SELL	$92.16 - $103.8 $39 Million - $43.9 Million	-422,742 Reduced 25.24%	1,252,325 $123 Million
Q4 2017 Feb 14, 2018	BUY	$85.26 - $94.62 $7.41 Million - $8.22 Million	86,926 Added 5.47%	1,675,067 $155 Million
Q3 2017 Nov 14, 2017	BUY	$79.29 - $88.45 $126 Million - $140 Million	1,588,141	1,588,141 $136 Million

Others Institutions Holding DHR

# of Institutions

2,443

Shares Held

563M

Call Options Held

3.91M

Put Options Held

4.1M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $180B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account